PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
Data generation and assessment | ARN | Regulatory risk management | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lithium perchlorate | 232-237-2 | 7791-03-9 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium phosphorodifluoridate | 643-080-8 | 24389-25-1 | - | - | 1 | - | 1 | - | - | - | - | Details |
Lithium salicylate | 209-011-7 | 552-38-5 | - | - | - | - | 1 | - | - | - | - | Details |
lithium sodium 2-amino-4-{[4-(cyanoazanidyl)-6-[(3-sulfonatophenyl)amino]-1,3,5-triazin-2-yl]amino}-5-(2-{4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)benzene-1-sulfonate | 413-090-5 | - | - | - | 1 | - | - | - | - | - | - | Details |
Lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
DIRECT BLUE FC 57087
|
418-870-9 | 154212-58-5 | - | - | - | - | - | 1 | - | - | - | Details |
Lithium stearate | 224-772-5 | 4485-12-5 | - | - | 1 | - | - | - | - | - | - | Details |
Lithium sulfate monohydrate | 600-157-0 | 10102-25-7 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium sulphate | 233-820-4 | 10377-48-7 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium sulphide, anhydrous | 235-228-1 | 12136-58-2 | - | - | - | - | 1 | - | - | - | - | Details |
Lithium tetrafluoroborate, anhydrous | 238-178-9 | 14283-07-9 | - | - | 1 | - | - | - | - | - | - | Details |
Lithium, sodium 2-(4-chloro-6-cyanoamino-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(2-methoxy-5-(sulfatoethanesulfonyl)phenylazo)naphthalene-1,7-disulfonate | 440-050-4 | - | - | - | 1 | - | - | - | - | - | - | Details |
Lithium-2-methoxyethoxide | 460-000-5 | 20246-63-3 | - | - | - | - | 1 | - | - | - | - | Details |
long chain alkyl thio carbamide metal complex | 457-320-2 | - | - | - | 2 | - | 1 | - | - | - | - | Details |
Long-chain perfluorocarboxylic acids, their salts and related compounds
Long-chain PFCAs and their salts are a homologous series of substances with the molecular formula of CnF2n+1CO2H (where 8 ≤ n ≤ 20). Related compounds are viewed as any substance that is a precursor and may degrade or transform to long-chain PFCAs, where the perfluorinated alkyl moiety has the formula CnF2n+1 (where 8 ≤ n ≤ 20) and is directly bonded to any chemical moiety other than a fluorine, chlorine or bromine atom
|
- | - | - | - | - | - | - | - | - | - | - | Details |
Lubricating oils, used | 274-635-9 | 70514-12-4 | - | - | 4 | - | - | - | - | - | - | Details |
Lysine hydrochloride | 211-519-9 | 657-27-2 | - | - | 1 | - | - | - | - | - | - | Details |
m-(2,3-epoxypropoxy)-N,N-bis(2,3-epoxypropyl)aniline | 275-662-9 | 71604-74-5 | - | - | 3 | - | 1 | - | - | - | - | Details |
m-bis(2,3-epoxypropoxy)benzene | 202-987-5 | 101-90-6 | - | - | - | - | 1 | 1 | - | - | - | Details |
m-cresol | 203-577-9 | 108-39-4 | - | - | 2 | - | - | - | - | - | - | Details |
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 258-067-9 | 52645-53-1 | - | - | - | - | - | 1 | - | - | - | Details |
m-phenylene di(acetate) | 203-596-2 | 108-58-7 | - | - | 1 | - | - | - | - | - | - | Details |
m-phenylenebis(methylamine) | 216-032-5 | 1477-55-0 | - | - | 4 | - | 1 | - | - | - | - | Details |
m-phenylenediamine | 203-584-7 | 108-45-2 | 1 | - | 1 | - | - | - | - | - | - | Details |
m-TDI oligomers, isocyanurate | 938-708-5 | - | - | - | 1 | - | 1 | - | - | - | - | Details |
m-terphenyl | 202-122-1 | 92-06-8 | - | - | - | - | 1 | - | - | - | - | Details |
m-toluidine | 203-583-1 | 108-44-1 | - | - | - | - | 1 | - | - | - | - | Details |
m-toluidinium chloride | 211-314-4 | 638-03-9 | - | - | - | - | 1 | - | - | - | - | Details |
m-tolyl isocyanate | 210-676-0 | 621-29-4 | - | - | - | - | 1 | - | - | - | - | Details |
m-tolylidene diisocyanate | 247-722-4 | 26471-62-5 | 1 | - | 1 | - | 2 | - | - | - | - | Details |
m-xylene | 203-576-3 | 108-38-3 | 1 | - | 3 | - | 1 | - | - | - | - | Details |
magnesia-stabilised zirconia | 939-960-9 | - | - | - | 2 | - | 1 | - | - | - | - | Details |
Magnesium 2-ethylhexanoate | 239-685-8 | 15602-15-0 | - | - | - | - | 1 | - | - | - | - | Details |
Magnesium acrylate | 227-177-9 | 5698-98-6 | - | - | - | - | 1 | - | - | - | - | Details |
Magnesium bis(2-ethylbutanoate) | 700-021-1 | 79992-76-0 | - | - | 1 | - | 1 | - | - | - | - | Details |
Magnesium bis(2-ethylbutanoate) | 421-140-2 | - | - | - | 1 | - | 1 | - | - | - | - | Details |
Magnesium carbonate | 208-915-9 | 546-93-0 | - | - | 1 | - | - | - | - | - | - | Details |
Magnesium dihydrogen disulphite | 237-403-8 | 13774-25-9 | - | - | 1 | - | - | - | - | - | - | Details |
Magnesium divanadium hexaoxide | 237-001-2 | 13573-13-2 | - | - | - | - | 1 | - | - | - | - | Details |
Magnesium hydroxide sulphate trihydrate | 483-390-9 | 12508-61-1 | - | - | 1 | - | - | - | - | - | - | Details |
Magnesium metaborate | 237-235-5 | 13703-82-7 | - | - | 2 | - | - | 1 | - | - | - | Details |
Magnesium neodecanoate | 260-742-8 | 57453-97-1 | - | - | - | - | 1 | - | - | - | - | Details |
Magnesium potassium fluoride silicate (Mg2.7K0.7Si4O10F2) | 949-694-5 | - | - | - | - | - | 1 | - | - | - | - | Details |
Magnesium silicate | 237-413-2 | 13776-74-4 | - | - | - | - | 1 | - | - | - | - | Details |
magnesium sodium fluoride silicate | 442-650-1 | 56450-90-9 | - | - | - | - | 1 | - | - | - | - | Details |
Magnesium sulphate | 231-298-2 | 7487-88-9 | - | - | 1 | - | - | - | - | - | - | Details |
Magnesium, bis(2-hydroxybenzoato-O1,O2)-, ar,ar'-di-C14-18alkyl derivs. | 931-371-5 | - | - | - | 4 | - | 1 | - | - | - | - | Details |
Malathion | 204-497-7 | 121-75-5 | - | - | - | - | 1 | 1 | - | - | - | Details |
Maleic acid | 203-742-5 | 110-16-7 | - | - | 1 | - | - | - | - | - | - | Details |
Maleic anhydride | 203-571-6 | 108-31-6 | 1 | - | - | - | - | 1 | - | - | - | Details |
Malononitrile | 203-703-2 | 109-77-3 | - | - | 1 | - | 1 | - | - | - | - | Details |